CollPlant Biotechnologies (CLGN) Inventory Average (2018 - 2026)

CollPlant Biotechnologies has reported Inventory Average for 9 years, with the latest figure at $626000.0 in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 99.89% year-over-year to $626000.0; the trailing twelve-month figure through Mar 2026 stood at $626000.0 (down 99.89% YoY), and the FY2025 full-year result was $220.3 million, changed 0.03% from the prior year.
• Inventory Average for Q1 2026 stood at $626000.0, down from $336.8 million in the prior quarter.
• The five-year high for Inventory Average was $540.5 billion in Q1 2022, with the low at $626000.0 in Q1 2026.
• Historically, Inventory Average has averaged $36.4 billion across 5 years, with a median of $336.8 million in 2025.
• Annual changes were most pronounced in 2022 — Inventory Average soared 84600.58% — and 2026, when it plunged 99.89%.
• CollPlant Biotechnologies' Inventory Average stood at $715.6 million in 2022, then climbed by 5.07% to $751.9 million in 2023, then plunged by 40.55% to $447.0 million in 2024, then fell by 24.66% to $336.8 million in 2025, then tumbled by 99.81% to $626000.0 in 2026.
• The last three Inventory Average figures came in at $626000.0 (Q1 2026), $336.8 million (Q2 2025), and $556.5 million (Q1 2025), per Business Quant data.